NCT00601588已完成不适用
A Single Dose, Two-Period, Two-Treatment, Two-Way Crossover Bioequivalency Study of Sertraline Tablets 100 mg Under Fed Conditions
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 43
- 试验地点
- 1
- 主要终点
- Bioequivalence
研究概览
简要总结
The objective of this study was the bioequivalence of a Roxane Laboratories' Sertraline Tablets, 100 mg, to Zoloft® Tablets, 100 mg (Pfizer) under fed conditions using a single-dose, 2-treatment, 2-period, crossover design.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 45 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •No clinically significant abnormal findings on the physical examination, medical history, or clinical laboratory results during screening.
排除标准
- •Positive test for HIV, Hepatitis B, or Hepatitis C.
- •Treatment with known enzyme altering drugs.
- •Treatment with any triptan within 30 days prior to or during the study.
- •History of allergic or adverse response to sertraline or any comparable or similar product.
结局指标
主要结局
Bioequivalence
时间窗: Baseline, Two period, Fourteen day washout
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Bioequivalency Study of Sertraline Under Fasting ConditionsDepressionNCT00602849Roxane Laboratories38
已完成
不适用
Bioequivalency Study of Zolpidem Tartrate Under Fed ConditionsInsomniaNCT00602719Roxane Laboratories30
已完成
不适用
Bioequivalency Study of Zolpidem Tartrate Under Fasting ConditionsInsomniaNCT00601666Roxane Laboratories30
已完成
不适用
Bioequivalency Study of Terbinafine Tablets Under Fasting ConditionsOnychomycosisNCT00602342Roxane Laboratories30
已完成
不适用
Bioequivalency Study of Terbinafine Tablets Under Fed ConditionsOnychomycosisNCT00602251Roxane Laboratories30